EN DE
Check 40,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

HealWELL AI Inc. (AIDX) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of HealWELL AI Inc. stock C$0.57, price C$0.59, that is 3.6% below the price, quality 23 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare CA · ISIN CA42249X1006

HA HealWELL AI Inc. logo Thin data Nov 11, 2026

HealWELL AI Inc.

AIDX · TO
Fairly valued, weak quality

The stock costs about what our calculation considers fair.

Low debt
Fair value C$0.5686 · Fairly valued
Expensive Growth (revenue 5y +21.9 %/yr in CAD)
Quality 23/100
Loss-making · -23.0% net margin (TTM)
Negative free cash flow
Trails peers (0/9)
Narrow moat 12/100 · thin data
Thin data
Estimate

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

C$3.04 C$0.0850 Fair Value C$0.5686 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.

How to read this chart

60‑month range C$0.0850 – C$3.04 · fair‑value band C$0.4264 – C$0.7107 · the C$0.5900 price screens above the C$0.5686 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 11, 2026.

Follow HealWELL AI in your weekly email

Every Wednesday you see whether HealWELL AI is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software.

Show moreShow less

It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases.

The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services.

It also offers rare and chronic disease screening, real world evidence clinical study generation, advanced clinical decision support, and physical ASI co-pilot tools. It serves public sector organizations, healthcare providers, insurers, and life science companies.

The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in September 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.

Stock analysis

HealWELL AI Inc. (AIDX) currently trades at C$0.5900, while our estimate is C$0.5686, so the stock looks roughly fairly valued today (gap 3.8%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: C$0.4264 (bear) to C$0.7107 (bull), the price of C$0.5900 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 23/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

HealWELL AI Inc. reported revenue of C$104M in FY2025 versus C$47.8M in FY2021, a compound +21.4%/yr. Reported net income was −C$46.9M in FY2025.

Key figures

Market cap C$224M (≈ $158M) Micro · P/S ratio 1.74 · EPS (TTM) C$−0.0900 · Net margin −23.0% · Return on equity −16.6% · Return on assets (EBIT) −27.1% (5-year average) · Operating margin −18.8% · Revenue (TTM) C$129M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).

What moves the price

The share trades about 54% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −4%, AIDX screens cheaper than that median.

Fair Value

Bear C$0.4264 Fair Value C$0.5686 Bull C$0.7107
Price C$0.5900 · Downside -3.6%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 23/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 9
How much profit the company makes from its sales and capital
Quality Growth 74
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 38
Debt, balance sheet and risk of trouble
Investment 33
Does it invest with discipline instead of growing at any price?
Low Volatility 52
How calm the share price moves, does not count
Price momentum 9
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+166.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+115.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.9%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−2.2% (2020) → −28.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch AIDX, get fair value alerts →

Compare HealWELL AI Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 246 stocks

Beats the industry median on 0/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 23 · Bottom 25%
Fair Value upside −3.6% · Below median
Profitability
Return on assets −16.5% · Bottom 25%
Net margin (12 months) −23.0% · Bottom 25%
Operating margin (12 months) −18.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −0.9% · Bottom 25%
Balance sheet
Debt / equity 0.46× · Above median

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B 1.81× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 1.74× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)29 · sector 33
FUTURE (revenue growth)0 · sector 33
PAST (return on equity)0 · sector 31
HEALTH (low debt)77 · sector 90
DIVIDEND (yield)0 · sector 39

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $22.74 $46.55 +105% vs AIDX
Aier Eye Hospital Group 300015 ¥8.85 ¥10.88 +23% vs AIDX
DaVita Inc DVA $179.28 $218.90 +22% vs AIDX
HCA Healthcare, Inc HCA $504.42 $547.34 +9% vs AIDX
Tenet Healthcare Corporation THC $290.27 $279.20 −4% vs AIDX
The Ensign Group ENSG $185.09 $140.09 −24% vs AIDX
Encompass Health Corporation EHC $142.51 $94.81 −33% vs AIDX
Fresenius SE FRE €53.47 €34.77 −35% vs AIDX
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,550 ₹5,234 −39% vs AIDX
Dr. Sulaiman Al Habib Medical Services Group 4013 214.70 SAR 109.45 SAR −49% vs AIDX

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

HealWELL AI Inc.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "HealWELL AI Inc. Fair Value". https://www.fairvalue-calculator.com/stock/AIDX.TO

Frequently asked questions

Is HealWELL AI Inc. (AIDX) overvalued or undervalued?
As of Nov 11, 2026, our estimate of fair value is C$0.5686 versus a price of C$0.5900, about 4% lower (fairly valued).
What is the fair value of AIDX?
Our estimate for HealWELL AI Inc. is C$0.5686 (as of Nov 11, 2026), built from audited fundamentals. The current price: C$0.5900.
What is the quality score of AIDX?
HealWELL AI Inc. has a Quality Score of 23/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HealWELL AI Inc. (AIDX)?
Our calculated price target is the estimate of C$0.5686 (as of Nov 11, 2026). Cautious scenario C$0.4264, optimistic scenario C$0.7107. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the HealWELL AI Inc. stock forecast for 2026?
Our estimate puts fair value at C$0.5686, about 4% lower versus a price of C$0.5900 (fairly valued). Cautious scenario C$0.4264, optimistic scenario C$0.7107. The calculation is refreshed regularly with new filings.
What is the revenue of HealWELL AI Inc. (AIDX)?
HealWELL AI Inc. reported trailing-twelve-month revenue of about C$129M (latest available figure, as of Nov 11, 2026).
What is the intrinsic value of HealWELL AI Inc. (AIDX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HealWELL AI Inc. it is C$0.5686 per share (as of Nov 11, 2026), against a price of C$0.5900.
Is HealWELL AI Inc. stock overvalued or undervalued in 2026?
As of Nov 11, 2026, AIDX trades above its calculated fair value: price C$0.5900, fair value C$0.5686, a gap of about −4% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AIDX?
No. The price is what the market pays today (C$0.5900); the fair value is what the company's own numbers justify (C$0.5686). For HealWELL AI Inc. the two are C$0.0214 per share apart. That gap is exactly why we show both numbers side by side.
How much is HealWELL AI Inc. worth?
The market values HealWELL AI Inc. at about C$224M (market capitalisation, as of Nov 11, 2026). Per share that is C$0.5900; our models calculate a fair value of C$0.5686 per share.
What do the bullish and bearish scenarios say about AIDX?
Our models span a range for HealWELL AI Inc.: cautious scenario C$0.4264, base C$0.5686, optimistic C$0.7107 per share (as of Nov 11, 2026, price C$0.5900). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of HealWELL AI Inc. (AIDX)?
Balance-sheet figures for HealWELL AI Inc. (as of Nov 11, 2026): return on equity −16.6%, debt of 0.46 per unit of equity. They feed the Quality Score of 23/100, which measures business quality independently of the share price.
How far is AIDX from its 52-week high?
HealWELL AI Inc. trades at C$0.5900, about 54% below its 52-week high of C$1.27 and at the low of C$0.5900 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.5686 is for.
Which stocks are comparable to HealWELL AI Inc.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HealWELL AI Inc. stock attractive at the current price?
The data as of Nov 11, 2026: price C$0.5900, calculated fair value C$0.5686 (−4%), Quality Score 23/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. HealWELL AI Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HealWELL AI Inc. (AIDX)?
The closing price on Nov 10, 2026 was C$0.5900. Our estimate is C$0.5686, about 4% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HealWELL AI Inc. right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of HealWELL AI Inc.

How large is the market capitalisation of HealWELL AI Inc. (AIDX)?
The market capitalisation of HealWELL AI Inc. is C$224M (≈ $158M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of HealWELL AI Inc. (AIDX)?
The price-to-sales ratio of HealWELL AI Inc. is 1.74 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of HealWELL AI Inc. (AIDX)?
Earnings per share at HealWELL AI Inc. are C$−0.0900. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of HealWELL AI Inc. (AIDX)?
The net margin of HealWELL AI Inc. is −23.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of HealWELL AI Inc. (AIDX)?
The return on equity (ROE) of HealWELL AI Inc. is −16.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HealWELL AI Inc. (AIDX)?
On an EBIT basis the return on assets of HealWELL AI Inc. is −27.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of HealWELL AI Inc. (AIDX)?
The operating margin of HealWELL AI Inc. is −18.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at HealWELL AI Inc. (AIDX)?
Revenue at HealWELL AI Inc. is growing −0.9% versus a year earlier (3y avg +115%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does HealWELL AI Inc. (AIDX) generate?
The free cash flow of HealWELL AI Inc. is −C$20.2M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does HealWELL AI Inc. (AIDX) carry?
The net debt of HealWELL AI Inc. is C$67.5M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Continue in the live analysis

Fair value and trend for 40,000+ stocks, watchlist, comparison and the diversification check.

Open the live analysis →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.